Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

Andreas Doesch, Matthias Helmschrott, Jan Beckendorf, Ceylan Akyol, Arjang Ruhparwar, Bastian Schmack, Christian Erbel, Christian A. Gleissner, Mohammadreza Akhavanpoor, Philipp Ehlermann,

Drug Design Development and Therapy · 2014 · 12 citations · 23 references

DOIFull text

Open access

Abstract

Our study demonstrated that a TAC-based primary immunosuppressive therapy is superior to a CSA-based immunosuppressive regimen in patients after HTX regarding time to first biopsy-proven rejection.

References

23